NORTH CAROLINA RESEARCHERS DISCOVER MRNA VACCINE THAT CURES THE URGE TO TALK ABOUT MRNA VACCINES
By Loop 'The Needle' Stitch (Sterile Waiting Room) — Tue, 21 Apr 2026 04:05:53 GMT
A breakthrough study in Raleigh suggests that a single dose could reduce dinner party arguments by 84% through the suppression of 'opinionated biology' receptors.
"We found that by targeting the part of the brain that believes it joined the CDC after one YouTube video, we can restore peace to holiday gatherings." — KEY SLUDGE FINDING
In what is being hailed as the greatest medical advancement since the discovery of the 'mute' button, cancer researchers in North Carolina have accidentally developed an mRNA vaccine that targets the specific neurological pathway responsible for unsolicited medical opinions. The vaccine, tentatively named 'Hush-vax,' was created during a trial for traditional cancer therapies when scientists noticed that the lab rats stopped trying to explain 'the science' to their handlers.
The breakthrough comes after a year of turmoil where public discourse was dominated by armchair immunologists. 'We realized that the real epidemic wasn't just the virus, but the overwhelming desire of every Uncle Bob in America to use the word "cytokine" incorrectly,' said Dr. Felicity 'Quiet' Pouch, Head of the Institute for Applied Silence.
The mechanism of the vaccine involves a proprietary lipid nanoparticle that coats the larynx whenever the patient attempts to say the words 'do your own research' or 'spike protein' in a public setting. Instead of an argument, the patient simply experiences a sudden, overwhelming interest in the weather or the current price of birdseed.
Early clinical trials have been overwhelmingly positive. Participants who previously spent eight hours a day arguing on Facebook now report a 95% increase in 'not being annoying.' One test subject, who had formerly self-identified as a 'bio-hacker,' stated that he no longer feels the need to explain his gut microbiome to the cashier at Whole Foods.
Update: The FDA is fast-tracking the approval of Hush-vax, though the agency is currently struggling to find a spokesperson who hasn't already been vaccinated and thus rendered unable to talk about the approval process.